Ultragenyx Pharmaceutical Inc. buy melinda
Start price
31.08.17
/
50%
€50.68
Target price
26.12.17
€63.14
Performance (%)
-14.69%
End price
26.12.17
€43.23
Summary
This prediction ended on 26.12.17 with a price of €43.23. The prediction for Ultragenyx Pharmaceutical Inc. disappointed with a performance of -14.69%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 8.571% | 8.571% | -53.202% | -56.221% |
| iShares Core DAX® | 0.608% | 0.340% | 12.057% | 58.100% |
| iShares Nasdaq 100 | 0.636% | -3.172% | 1.743% | 84.363% |
| iShares Nikkei 225® | -0.128% | 8.916% | 27.388% | 64.836% |
| iShares S&P 500 | 0.544% | -0.699% | 1.915% | 58.669% |
Comments by melinda for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
zu folgen
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€73.50
25.08.20
25.08.20
€77.00
04.11.21
04.11.21
1.36%
05.11.21
05.11.21
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€57.91
23.06.17
23.06.17
€76.67
20.07.17
20.07.17
8.44%
20.07.17
20.07.17
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€64.20
23.06.17
23.06.17
€85.00
20.07.17
20.07.17
8.44%
20.07.17
20.07.17
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€68.19
05.01.17
05.01.17
€76.67
27.02.17
27.02.17
12.65%
27.02.17
27.02.17


